Biotechnology and the Diagnosis of Genetic Disease

This conference will provide for an exchange of information about the scientific, clinical, and societal issues associated with the application of biotechnology assays to the diagnosis of genetic disease. Its purposes are to focus on the policymaking implications of new biotechnologies at the federal level; assist the FDA in determining criteria for evaluating safety and efficacy of the technology; provide information for manufacturers to use in developing clinical trials; and serve as a forum for discussion among policymakers, manufacturers, researchers, clinicians, and genetic information users on the societal, economic, and reimbursement issues associated with the new technologies. Conference date: April 18-20, 1991, Alexandria, Virginia (Co-funded with FDA)